Overview Financials News + Filings Key Docs Ownership
|
Gracell Biotechnologies Inc.
|
|
|
Portfolio as of: |
Name | Shares | Change | Value | % Port | % OS | Hist | Date |
MARSHALL WACE, LLP
| 225,628 | 225,628 | 859,641,000 | 0.00 | |
Hist
| 06/30/2023 |
FRED ALGER MANAGEMENT, LLC
| 95,812 | 95,812 | 365,044,000 | 0.00 | |
Hist
| 06/30/2023 |
GOLDMAN SACHS GROUP INC
| 17,469 | -5,850 | 32,492,000 | 0.00 | |
Hist
| 03/31/2023 |
JPMORGAN CHASE & CO
| 2,265 | 62 | 8,630,000 | 0.00 | |
Hist
| 06/30/2023 |
Marshall Wace North America L.P.
| 82,348 | -21 | 1,142,000 | 0.00 | |
Hist
| 09/30/2021 |
NewEdge Advisors, LLC
| 227 | 227 | 865,000 | 0.00 | |
Hist
| 06/30/2023 |
Eagle Bay Advisors LLC
| 210 | 0 | 800,000 | 0.00 | |
Hist
| 06/30/2023 |
BARCLAYS PLC
| 10,517 | -29,913 | 40,000 | 0.00 | |
Hist
| 06/30/2023 |
China Universal Asset Management Co., Ltd.
| 678 | 678 | 2,000 | 0.00 | |
Hist
| 12/31/2022 |
|
|
|
|